Aeglea Biotherapeutics shares owned by Paradigm Biocapital Advisors
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Paradigm Biocapital Advisors
from 13F filings
Historical chart of Paradigm Biocapital Advisors investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Paradigm Biocapital Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aeglea Biotherapeutics by Paradigm Biocapital Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $25M | 1.5M | 16.76 |
| 2025-06-30 | $28M | 1.9M | 14.97 |
| 2025-03-31 | $34M | 2.1M | 16.14 |
| 2024-12-31 | $36M | 1.5M | 23.28 |
| 2024-09-30 | $37M | 1.3M | 29.41 |
More positions owned by Paradigm Biocapital Advisors
View all positions for Paradigm Biocapital Advisors